Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Use of the Atkins Diet for Children With Sturge Weber Syndrome
This study is currently recruiting participants.
Verified by Johns Hopkins University, March 2008
Sponsors and Collaborators: Johns Hopkins University
Vascular Birthmarks Foundation
Information provided by: Johns Hopkins University
ClinicalTrials.gov Identifier: NCT00639730
  Purpose

This research is being done to find out if the Atkins Diet can be used safely and effectively to reduce seizures in children who have Sturge Weber syndrome.

The ketogenic diet is a proven therapy for epilepsy, but can be difficult to use in children. The Atkins Diet is a high fat, high protein, low carbohydrate diet introduced in the 1970s to help with weight loss. It is different from the ketogenic diet in four major ways: no calorie restriction, no fluid restriction, no protein restriction, and is easy to start outside the hospital. People on the Atkins Diet become ketotic (produce high levels of ketones, a certain substance in the body), like patients on the ketogenic diet, and we believe this may lead to seizure control.

Children aged 2-18 with Sturge Weber syndrome and seizures at least monthly, who have used at least two anti-seizure drugs may join. 5 children in total will be enrolled.


Condition Intervention Phase
Epilepsy
Sturge Weber Syndrome
Dietary Supplement: modified Atkins diet
Phase I

Genetics Home Reference related topics: hypohidrotic ectodermal dysplasia pyridoxal 5'-phosphate-dependent epilepsy
MedlinePlus related topics: Epilepsy Seizures
U.S. FDA Resources
Study Type: Interventional
Study Design: Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Safety/Efficacy Study
Official Title: Use of the Atkins Diet for Children With Sturge Weber Syndrome

Further study details as provided by Johns Hopkins University:

Primary Outcome Measures:
  • Seizure reduction [ Time Frame: 6 months ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Ketosis [ Time Frame: 6 months ] [ Designated as safety issue: No ]
  • Safety (stroke like events) [ Time Frame: 6 months ] [ Designated as safety issue: Yes ]

Estimated Enrollment: 5
Study Start Date: May 2006
Estimated Study Completion Date: July 2010
Estimated Primary Completion Date: March 2010 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
A: Experimental
This is open-label - all patients are placed on the diet. There is no control or placebo arm.
Dietary Supplement: modified Atkins diet
High fat, low carbohydrate diet

Detailed Description:

If you agree to be in this study, we will ask you to do the following things:

Before the diet is started:

  • We will ask you to keep track of your child's seizures daily for 2 weeks before starting the Atkins diet and provide us with a 3-day food record as well.
  • Baseline blood (about 2 teaspoons) and urine work will be obtained.
  • We will give you a free copy of a carbohydrate-counting guide.
  • You will be asked to fill out a 3-day food record.

On the diet:

  • Give your child a daily calcium supplement and multivitamin.
  • Keep a daily seizure log.
  • Check urine for ketones (to make sure the diet is working) and specific gravity (to make sure your child is well hydrated) twice a week and when you come to clinic.
  • We will ask you to weigh your child at home every week, and we will weigh him or her when you come into clinic too.
  • Do not fluid restrict your child; please give plenty of carbohydrate-free fluids.
  • You will give 20 grams per day of carbohydrates. We will give you instructions on how to measure daily intake of carbohydrates.
  • We will not change medications for the first three months. Do not change your child's seizure medicines without checking with our doctors.
  • For the first three months, we ask you to avoid store-bought low-carbohydrate products (as they can have more carbohydrates than advertised).

After being on the diet for one month, Dr. Kossoff will contact you by telephone to discuss how your child is doing. You can also speak with one of our dietitians. We will discuss the 3-day food record with you

You will be asked to come to the clinic (outpatient center, 5th floor) for two follow-up visits:

  1. after being on the diet for 3 months and
  2. after being on the diet for 6 months.

During these visits you will meet with one of our doctors and a dietitian. We will review your child's seizure control and health. We may obtain blood (about 2 teaspoons). We will check your child's urine for ketones and specific gravity.

If the diet is helping beyond 6 months, we will help your child continue on the diet with clinic visits and labs as necessary, at a carbohydrate amount that is most helpful.

  Eligibility

Ages Eligible for Study:   2 Years to 18 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • 2-18 years
  • Sturge Weber syndrome
  • Monthly seizures (at least)
  • Tried at least two anticonvulsants

Exclusion Criteria:

  • Prior use of the Atkins or ketogenic diets
  • Patients with non-epileptic seizures (pseudoseizures) will be excluded
  • Patients that are pregnant or become pregnant during the study will be excluded
  • High cholesterol
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00639730

Contacts
Contact: Eric H Kossoff, MD 410-614-6054 ekossoff@jhmi.edu

Locations
United States, Maryland
Johns Hopkins Hospital Recruiting
Baltimore, Maryland, United States, 21287
Contact: Eric H Kossoff, MD     410-614-6054     ekossoff@jhmi.edu    
Principal Investigator: Eric H Kossoff, MD            
Sub-Investigator: Anne M Comi, MD            
Sub-Investigator: Zahava Turner, RD            
Sponsors and Collaborators
Johns Hopkins University
Vascular Birthmarks Foundation
Investigators
Principal Investigator: Eric H Kossoff, MD Johns Hopkins School of Medicine
  More Information

Publications:
Responsible Party: Johns Hopkins School of Medicine ( Eric Kossoff MD )
Study ID Numbers: NA_00003359
Study First Received: March 14, 2008
Last Updated: March 14, 2008
ClinicalTrials.gov Identifier: NCT00639730  
Health Authority: Johns Hopkins School of Medicine United States:

Keywords provided by Johns Hopkins University:
Epilepsy

Study placed in the following topic categories:
Angiomatosis
Cerebral Infarction
Brain Diseases
Klippel-Trenaunay-Weber Syndrome
Cerebrovascular Disorders
Parkes Weber syndrome
Weber syndrome
Sturge-Weber Syndrome
Hemangioma
Abnormalities, Multiple
Brain Ischemia
Congenital Abnormalities
Ectodermal Dysplasia
Skin Diseases, Genetic
Neurocutaneous Syndromes
Skin Diseases
Stroke
Vascular Diseases
Skin Abnormalities
Central Nervous System Diseases
Sturge-Weber syndrome
Ischemia
Brain Stem Infarctions
Ectodermal dysplasia
Genetic Diseases, Inborn
Epilepsy
Klippel Trenaunay Weber syndrome
Brain Infarction
Infarction
Ectodermal dysplasias

Additional relevant MeSH terms:
Neoplasms
Pathologic Processes
Disease
Neoplasms by Histologic Type
Syndrome
Nervous System Diseases
Neoplasms, Vascular Tissue
Cardiovascular Diseases

ClinicalTrials.gov processed this record on January 16, 2009